Mixed Dyslipidemia: Clinical Trials

2 trials for Mixed Dyslipidemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Mixed Dyslipidemia: new trials by email Literature Review of Mixed Dyslipidemia trials Research Report on Mixed Dyslipidemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
inclisiran - Primary Hypercholesterolemia, Mixed Dyslipidemia
Phase 4CompletedNovartis Pharmaceuticals652024-11-122026-06-23
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
pitavastatin, pravastatin - Primary Dyslipidemia, Mixed Dyslipidemia
Phase 4CompletedKowa Research Institute, Inc.3282010-10-012012-05-08

Interventions

ALN-PCS (1)  ·  Pravastatin (1)  ·  pitavastatin (1)

Sponsors

Kowa Research Institute, Inc. (1)  ·  Novartis Pharmaceuticals (1)

Countries

India (1)  ·  United States (1)

Results publications

PMID 24328357, PMID 24998014, PMID 26922296